Who Paid My Doc
FreeStyle Libre
Device Diabetes Care
PDI 00357599000226
General payments
$1,544,463
Research payments
$14,393,809
Through program year 2025, $1,544,463 in general payments and $14,393,809 in research payments were reported against FreeStyle Libre (Diabetes Care).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $583,838 | 4,282 |
| 2025 | Research | $1,216,017 | 309 |
| 2024 | General | $183,992 | 5,339 |
| 2024 | Research | $6,708,501 | 1,223 |
| 2023 | General | $260,024 | 6,101 |
| 2023 | Research | $4,376,441 | 366 |
| 2022 | General | $250,358 | 8,217 |
| 2022 | Research | $243,376 | 155 |
| 2021 | General | $266,252 | 11,833 |
| 2021 | Research | $1,849,475 | 567 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 63 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 42 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
35,772 general · 2,620 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.